Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Sterile Lancets Market Insights, Forecast to 2030

Global Sterile Lancets Market Insights, Forecast to 2030

Industry: Medical Devices & Consumables

Published Date: 2024-10-23

Pages: 198 Pages

Report ld: 3351436

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Sterile Lancets Market Size(US$)

CAGR 2024-2030

4.6%

Market Size,2030

USD 2,196

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 1,674 million

Market Forecast in 2030(Value)

US$ 2,196 million

CAGR

4.6%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.

The global Sterile Lancets market is projected to grow from US$ 1674 million in 2024 to US$ 2196 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period.

Market Drivers:

Growing prevalence of chronic diseases: The rise in chronic conditions like diabetes, which require regular blood glucose monitoring, is a significant driver for lancet demand. As the number of diabetes patients increases globally, the need for Sterile Lancets continues to grow.

Technological advancements in Sterile Lancets: Innovations such as ultra-thin needles, painless lancet designs, and easy-to-use lancet devices improve user experience, making blood sampling more comfortable and encouraging more frequent use.

Increase in home-based healthcare: The trend toward home healthcare and self-monitoring for various conditions, especially diabetes, has driven the use of Sterile Lancets. This allows patients to monitor their health in a more convenient and cost-effective way, increasing the market for these devices.

Aging population: The growing elderly population is more prone to chronic diseases like diabetes, requiring regular blood monitoring. This demographic shift is a major factor pushing the demand for Sterile Lancets and other monitoring devices.

Rising awareness of preventive healthcare: Increasing awareness of the importance of regular health monitoring, especially for managing conditions like diabetes, has led to higher adoption of Sterile Lancets for routine blood tests and glucose monitoring.

Market Challenges:

Competition from alternative technologies: Non-invasive blood glucose monitoring methods (such as continuous glucose monitors or sensor-based systems) are gaining traction, potentially reducing the reliance on traditional Sterile Lancets for blood sampling.

High recurring costs for patients: Sterile Lancets are single-use devices, and the recurring cost for people who need frequent testing can become a financial burden, particularly in low-income regions or for uninsured patients, limiting market growth.

Infection risks: Improper or repeated use of Sterile Lancets can lead to infections, particularly if they are not disposed of properly or if reused by mistake, which poses a health risk and deters their use.

Environmental concerns: Sterile Lancets contribute to medical waste, as they are disposable devices, raising concerns about environmental impact. This could lead to regulatory pressures or a shift toward more sustainable alternatives.

Regulatory compliance and approval hurdles: The lancet market is subject to stringent regulations and approval processes from health authorities. This can slow down the introduction of new products and innovations, delaying their availability in the market.

The classification of Sterile Lancets includes Ordinary Sterile Lancets and Safety Sterile Lancets. In 2023, Ordinary Sterile Lancets accounted for a share of 61.81% in the global Sterile Lancets market. With several hospitals and healthcare facilities converting to safety Sterile Lancets, this market share is poised for declined. Americas is the largest consumption place, with a consumption market share nearly 40 % in 2022. Following Americas, Europe is the second largest consumption place with the consumption market share of 30 %.

Report Includes

This report presents an overview of global market for Sterile Lancets, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Sterile Lancets, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Sterile Lancets, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sterile Lancets sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Sterile Lancets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Sterile Lancets sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Roche, Lifescan, BD, Ascensia, Abbott, B. Braun, ARKRAY, Terumo, I-SENS, Nipro, etc.

MARKET SEGMENTATION

By Company

Roche
Lifescan
BD
Ascensia
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Cardinal Health
ICU Medical
Sarstedt
Sinocare
Yicheng
Yuwell
Greiner Bio One
Guangzhou iCare Medical
Shandong Lianfa
Tianjin Huahong
Owen Mumford
HemoCue
HTL-STREFA
UltiMed
SteriLance Medical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Safety Lancets
Ordinary Lancets

Segment by Application

Children's Fingertip Blood Tests
Glucose Tests
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Sterile Lancets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Sterile Lancets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: China by Type, and by Application, sales, and revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sterile Lancets sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Sterile Lancets Product Introduction

1.2 Market by Type

1.2.1 Global Sterile Lancets Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Safety Lancets

1.2.3 Ordinary Lancets

1.3 Market by Application

1.3.1 Global Sterile Lancets Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Children's Fingertip Blood Tests

1.3.3 Glucose Tests

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Sterile Lancets Revenue Estimates and Forecasts 2019-2030

2.2 Global Sterile Lancets Revenue by Region

2.2.1 Global Sterile Lancets Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Sterile Lancets Revenue by Region (2019-2024)

2.2.3 Global Sterile Lancets Revenue by Region (2025-2030)

2.2.4 Global Sterile Lancets Revenue Market Share by Region (2019-2030)

2.3 Global Sterile Lancets Sales Estimates and Forecasts 2019-2030

2.4 Global Sterile Lancets Sales by Region

2.4.1 Global Sterile Lancets Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Sterile Lancets Sales by Region (2019-2024)

2.4.3 Global Sterile Lancets Sales by Region (2025-2030)

2.4.4 Global Sterile Lancets Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

3.1 Global Sterile Lancets Sales by Manufacturers

3.1.1 Global Sterile Lancets Sales by Manufacturers (2019-2024)

3.1.2 Global Sterile Lancets Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sterile Lancets in 2023

3.2 Global Sterile Lancets Revenue by Manufacturers

3.2.1 Global Sterile Lancets Revenue by Manufacturers (2019-2024)

3.2.2 Global Sterile Lancets Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Sterile Lancets Revenue in 2023

3.3 Global Key Players of Sterile Lancets, Industry Ranking, 2021 VS 2022

3.4 Global Sterile Lancets Sales Price by Manufacturers (2019-2024)

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Sterile Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Sterile Lancets, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Sterile Lancets, Product Offered and Application

3.8 Global Key Manufacturers of Sterile Lancets, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Sterile Lancets Sales by Type

4.1.1 Global Sterile Lancets Historical Sales by Type (2019-2024)

4.1.2 Global Sterile Lancets Forecasted Sales by Type (2025-2030)

4.1.3 Global Sterile Lancets Sales Market Share by Type (2019-2030)

4.2 Global Sterile Lancets Revenue by Type

4.2.1 Global Sterile Lancets Historical Revenue by Type (2019-2024)

4.2.2 Global Sterile Lancets Forecasted Revenue by Type (2025-2030)

4.2.3 Global Sterile Lancets Revenue Market Share by Type (2019-2030)

4.3 Global Sterile Lancets Price by Type

4.3.1 Global Sterile Lancets Price by Type (2019-2024)

4.3.2 Global Sterile Lancets Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Sterile Lancets Sales by Application

5.1.1 Global Sterile Lancets Historical Sales by Application (2019-2024)

5.1.2 Global Sterile Lancets Forecasted Sales by Application (2025-2030)

5.1.3 Global Sterile Lancets Sales Market Share by Application (2019-2030)

5.2 Global Sterile Lancets Revenue by Application

5.2.1 Global Sterile Lancets Historical Revenue by Application (2019-2024)

5.2.2 Global Sterile Lancets Forecasted Revenue by Application (2025-2030)

5.2.3 Global Sterile Lancets Revenue Market Share by Application (2019-2030)

5.3 Global Sterile Lancets Price by Application

5.3.1 Global Sterile Lancets Price by Application (2019-2024)

5.3.2 Global Sterile Lancets Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Sterile Lancets Market Size by Type

6.1.1 US & Canada Sterile Lancets Sales by Type (2019-2030)

6.1.2 US & Canada Sterile Lancets Revenue by Type (2019-2030)

6.2 US & Canada Sterile Lancets Market Size by Application

6.2.1 US & Canada Sterile Lancets Sales by Application (2019-2030)

6.2.2 US & Canada Sterile Lancets Revenue by Application (2019-2030)

6.3 US & Canada Sterile Lancets Market Size by Country

6.3.1 US & Canada Sterile Lancets Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Sterile Lancets Revenue by Country (2019-2030)

6.3.3 US & Canada Sterile Lancets Sales by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Sterile Lancets Market Size by Type

7.1.1 Europe Sterile Lancets Sales by Type (2019-2030)

7.1.2 Europe Sterile Lancets Revenue by Type (2019-2030)

7.2 Europe Sterile Lancets Market Size by Application

7.2.1 Europe Sterile Lancets Sales by Application (2019-2030)

7.2.2 Europe Sterile Lancets Revenue by Application (2019-2030)

7.3 Europe Sterile Lancets Market Size by Country

7.3.1 Europe Sterile Lancets Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Sterile Lancets Revenue by Country (2019-2030)

7.3.3 Europe Sterile Lancets Sales by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Sterile Lancets Market Size by Type

8.1.1 China Sterile Lancets Sales by Type (2019-2030)

8.1.2 China Sterile Lancets Revenue by Type (2019-2030)

8.2 China Sterile Lancets Market Size by Application

8.2.1 China Sterile Lancets Sales by Application (2019-2030)

8.2.2 China Sterile Lancets Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Sterile Lancets Market Size by Type

9.1.1 Asia Sterile Lancets Sales by Type (2019-2030)

9.1.2 Asia Sterile Lancets Revenue by Type (2019-2030)

9.2 Asia Sterile Lancets Market Size by Application

9.2.1 Asia Sterile Lancets Sales by Application (2019-2030)

9.2.2 Asia Sterile Lancets Revenue by Application (2019-2030)

9.3 Asia Sterile Lancets Market Size by Region

9.3.1 Asia Sterile Lancets Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Sterile Lancets Revenue by Region (2019-2030)

9.3.3 Asia Sterile Lancets Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

9.3.9 Australia

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Sterile Lancets Market Size by Type

10.1.1 Middle East, Africa and Latin America Sterile Lancets Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Sterile Lancets Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Sterile Lancets Market Size by Application

10.2.1 Middle East, Africa and Latin America Sterile Lancets Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Sterile Lancets Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Sterile Lancets Market Size by Country

10.3.1 Middle East, Africa and Latin America Sterile Lancets Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Sterile Lancets Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Sterile Lancets Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Corporate Profile

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Overview

11.1.3 Roche Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Roche Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Roche Recent Developments

11.2 Lifescan

11.2.1 Lifescan Company Information

11.2.2 Lifescan Overview

11.2.3 Lifescan Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Lifescan Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Lifescan Recent Developments

11.3 BD

11.3.1 BD Company Information

11.3.2 BD Overview

11.3.3 BD Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 BD Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 BD Recent Developments

11.4 Ascensia

11.4.1 Ascensia Company Information

11.4.2 Ascensia Overview

11.4.3 Ascensia Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Ascensia Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Ascensia Recent Developments

11.5 Abbott

11.5.1 Abbott Company Information

11.5.2 Abbott Overview

11.5.3 Abbott Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Abbott Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Abbott Recent Developments

11.6 B. Braun

11.6.1 B. Braun Company Information

11.6.2 B. Braun Overview

11.6.3 B. Braun Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 B. Braun Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 B. Braun Recent Developments

11.7 ARKRAY

11.7.1 ARKRAY Company Information

11.7.2 ARKRAY Overview

11.7.3 ARKRAY Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 ARKRAY Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 ARKRAY Recent Developments

11.8 Terumo

11.8.1 Terumo Company Information

11.8.2 Terumo Overview

11.8.3 Terumo Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Terumo Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Terumo Recent Developments

11.9 I-SENS

11.9.1 I-SENS Company Information

11.9.2 I-SENS Overview

11.9.3 I-SENS Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 I-SENS Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 I-SENS Recent Developments

11.10 Nipro

11.10.1 Nipro Company Information

11.10.2 Nipro Overview

11.10.3 Nipro Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Nipro Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Nipro Recent Developments

11.11 Cardinal Health

11.11.1 Cardinal Health Company Information

11.11.2 Cardinal Health Overview

11.11.3 Cardinal Health Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Cardinal Health Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Cardinal Health Recent Developments

11.12 ICU Medical

11.12.1 ICU Medical Company Information

11.12.2 ICU Medical Overview

11.12.3 ICU Medical Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 ICU Medical Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 ICU Medical Recent Developments

11.13 Sarstedt

11.13.1 Sarstedt Company Information

11.13.2 Sarstedt Overview

11.13.3 Sarstedt Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.13.4 Sarstedt Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Sarstedt Recent Developments

11.14 Sinocare

11.14.1 Sinocare Company Information

11.14.2 Sinocare Overview

11.14.3 Sinocare Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.14.4 Sinocare Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Sinocare Recent Developments

11.15 Yicheng

11.15.1 Yicheng Company Information

11.15.2 Yicheng Overview

11.15.3 Yicheng Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.15.4 Yicheng Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Yicheng Recent Developments

11.16 Yuwell

11.16.1 Yuwell Company Information

11.16.2 Yuwell Overview

11.16.3 Yuwell Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.16.4 Yuwell Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 Yuwell Recent Developments

11.17 Greiner Bio One

11.17.1 Greiner Bio One Company Information

11.17.2 Greiner Bio One Overview

11.17.3 Greiner Bio One Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.17.4 Greiner Bio One Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.17.5 Greiner Bio One Recent Developments

11.18 Guangzhou iCare Medical

11.18.1 Guangzhou iCare Medical Company Information

11.18.2 Guangzhou iCare Medical Overview

11.18.3 Guangzhou iCare Medical Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.18.4 Guangzhou iCare Medical Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.18.5 Guangzhou iCare Medical Recent Developments

11.19 Shandong Lianfa

11.19.1 Shandong Lianfa Company Information

11.19.2 Shandong Lianfa Overview

11.19.3 Shandong Lianfa Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.19.4 Shandong Lianfa Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.19.5 Shandong Lianfa Recent Developments

11.20 Tianjin Huahong

11.20.1 Tianjin Huahong Company Information

11.20.2 Tianjin Huahong Overview

11.20.3 Tianjin Huahong Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.20.4 Tianjin Huahong Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.20.5 Tianjin Huahong Recent Developments

11.21 Owen Mumford

11.21.1 Owen Mumford Company Information

11.21.2 Owen Mumford Overview

11.21.3 Owen Mumford Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.21.4 Owen Mumford Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.21.5 Owen Mumford Recent Developments

11.22 HemoCue

11.22.1 HemoCue Company Information

11.22.2 HemoCue Overview

11.22.3 HemoCue Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.22.4 HemoCue Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.22.5 HemoCue Recent Developments

11.23 HTL-STREFA

11.23.1 HTL-STREFA Company Information

11.23.2 HTL-STREFA Overview

11.23.3 HTL-STREFA Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.23.4 HTL-STREFA Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.23.5 HTL-STREFA Recent Developments

11.24 UltiMed

11.24.1 UltiMed Company Information

11.24.2 UltiMed Overview

11.24.3 UltiMed Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.24.4 UltiMed Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.24.5 UltiMed Recent Developments

11.25 SteriLance Medical

11.25.1 SteriLance Medical Company Information

11.25.2 SteriLance Medical Overview

11.25.3 SteriLance Medical Sterile Lancets Sales, Price, Revenue and Gross Margin (2019-2024)

11.25.4 SteriLance Medical Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

11.25.5 SteriLance Medical Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Sterile Lancets Industry Chain Analysis

12.2 Sterile Lancets Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Sterile Lancets Production Mode & Process

12.4 Sterile Lancets Sales and Marketing

12.4.1 Sterile Lancets Sales Channels

12.4.2 Sterile Lancets Distributors

12.5 Sterile Lancets Customers

13 Sterile Lancets Market Dynamics

13.1 Sterile Lancets Industry Trends

13.2 Sterile Lancets Market Drivers

13.3 Sterile Lancets Market Challenges

13.4 Sterile Lancets Market Restraints

14 Key Findings in the Global Sterile Lancets Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

15.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Sterile Lancets Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Safety Lancets

Table 3. Major Manufacturers of Ordinary Lancets

Table 4. Global Sterile Lancets Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Sterile Lancets Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Sterile Lancets Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Sterile Lancets Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Sterile Lancets Revenue Market Share by Region (2019-2024)

Table 9. Global Sterile Lancets Revenue Market Share by Region (2025-2030)

Table 10. Global Sterile Lancets Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 11. Global Sterile Lancets Sales by Region (2019-2024) & (K Units)

Table 12. Global Sterile Lancets Sales by Region (2025-2030) & (K Units)

Table 13. Global Sterile Lancets Sales Market Share by Region (2019-2024)

Table 14. Global Sterile Lancets Sales Market Share by Region (2025-2030)

Table 15. Global Sterile Lancets Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Sterile Lancets Sales Share by Manufacturers (2019-2024)

Table 17. Global Sterile Lancets Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Sterile Lancets Revenue Market Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Sterile Lancets, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Sterile Lancets Price by Manufacturers (2019-2024) & (US$/Unit)

Table 21. Global Sterile Lancets Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Sterile Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Lancets as of 2023)

Table 23. Global Key Manufacturers of Sterile Lancets, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Sterile Lancets, Product Offered and Application

Table 25. Global Key Manufacturers of Sterile Lancets, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Sterile Lancets Sales by Type (2019-2024) & (K Units)

Table 28. Global Sterile Lancets Sales by Type (2025-2030) & (K Units)

Table 29. Global Sterile Lancets Sales Share by Type (2019-2024)

Table 30. Global Sterile Lancets Sales Share by Type (2025-2030)

Table 31. Global Sterile Lancets Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Sterile Lancets Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Sterile Lancets Revenue Share by Type (2019-2024)

Table 34. Global Sterile Lancets Revenue Share by Type (2025-2030)

Table 35. Sterile Lancets Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Sterile Lancets Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Sterile Lancets Sales by Application (2019-2024) & (K Units)

Table 38. Global Sterile Lancets Sales by Application (2025-2030) & (K Units)

Table 39. Global Sterile Lancets Sales Share by Application (2019-2024)

Table 40. Global Sterile Lancets Sales Share by Application (2025-2030)

Table 41. Global Sterile Lancets Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Sterile Lancets Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Sterile Lancets Revenue Share by Application (2019-2024)

Table 44. Global Sterile Lancets Revenue Share by Application (2025-2030)

Table 45. Sterile Lancets Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Sterile Lancets Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Sterile Lancets Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Sterile Lancets Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Sterile Lancets Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Sterile Lancets Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Sterile Lancets Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Sterile Lancets Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Sterile Lancets Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Sterile Lancets Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Sterile Lancets Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Sterile Lancets Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Sterile Lancets Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Sterile Lancets Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Sterile Lancets Sales by Country (2025-2030) & (K Units)

Table 60. Europe Sterile Lancets Sales by Type (2019-2024) & (K Units)

Table 61. Europe Sterile Lancets Sales by Type (2025-2030) & (K Units)

Table 62. Europe Sterile Lancets Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Sterile Lancets Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Sterile Lancets Sales by Application (2019-2024) & (K Units)

Table 65. Europe Sterile Lancets Sales by Application (2025-2030) & (K Units)

Table 66. Europe Sterile Lancets Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Sterile Lancets Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Sterile Lancets Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Sterile Lancets Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Sterile Lancets Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Sterile Lancets Sales by Country (2019-2024) & (K Units)

Table 72. Europe Sterile Lancets Sales by Country (2025-2030) & (K Units)

Table 73. China Sterile Lancets Sales by Type (2019-2024) & (K Units)

Table 74. China Sterile Lancets Sales by Type (2025-2030) & (K Units)

Table 75. China Sterile Lancets Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Sterile Lancets Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Sterile Lancets Sales by Application (2019-2024) & (K Units)

Table 78. China Sterile Lancets Sales by Application (2025-2030) & (K Units)

Table 79. China Sterile Lancets Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Sterile Lancets Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Sterile Lancets Sales by Type (2019-2024) & (K Units)

Table 82. Asia Sterile Lancets Sales by Type (2025-2030) & (K Units)

Table 83. Asia Sterile Lancets Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Sterile Lancets Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Sterile Lancets Sales by Application (2019-2024) & (K Units)

Table 86. Asia Sterile Lancets Sales by Application (2025-2030) & (K Units)

Table 87. Asia Sterile Lancets Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Sterile Lancets Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Sterile Lancets Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Sterile Lancets Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Sterile Lancets Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Sterile Lancets Sales by Region (2019-2024) & (K Units)

Table 93. Asia Sterile Lancets Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Sterile Lancets Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Sterile Lancets Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Sterile Lancets Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Sterile Lancets Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Sterile Lancets Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Sterile Lancets Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Sterile Lancets Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Sterile Lancets Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Sterile Lancets Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Sterile Lancets Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Sterile Lancets Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Sterile Lancets Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Sterile Lancets Sales by Country (2025-2030) & (K Units)

Table 107. Roche Company Information

Table 108. Roche Description and Major Businesses

Table 109. Roche Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Roche Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Roche Recent Developments

Table 112. Lifescan Company Information

Table 113. Lifescan Description and Major Businesses

Table 114. Lifescan Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Lifescan Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Lifescan Recent Developments

Table 117. BD Company Information

Table 118. BD Description and Major Businesses

Table 119. BD Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. BD Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. BD Recent Developments

Table 122. Ascensia Company Information

Table 123. Ascensia Description and Major Businesses

Table 124. Ascensia Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Ascensia Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Ascensia Recent Developments

Table 127. Abbott Company Information

Table 128. Abbott Description and Major Businesses

Table 129. Abbott Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Abbott Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Abbott Recent Developments

Table 132. B. Braun Company Information

Table 133. B. Braun Description and Major Businesses

Table 134. B. Braun Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. B. Braun Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. B. Braun Recent Developments

Table 137. ARKRAY Company Information

Table 138. ARKRAY Description and Major Businesses

Table 139. ARKRAY Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. ARKRAY Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. ARKRAY Recent Developments

Table 142. Terumo Company Information

Table 143. Terumo Description and Major Businesses

Table 144. Terumo Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 145. Terumo Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Terumo Recent Developments

Table 147. I-SENS Company Information

Table 148. I-SENS Description and Major Businesses

Table 149. I-SENS Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 150. I-SENS Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. I-SENS Recent Developments

Table 152. Nipro Company Information

Table 153. Nipro Description and Major Businesses

Table 154. Nipro Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 155. Nipro Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Nipro Recent Developments

Table 157. Cardinal Health Company Information

Table 158. Cardinal Health Description and Major Businesses

Table 159. Cardinal Health Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 160. Cardinal Health Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Cardinal Health Recent Developments

Table 162. ICU Medical Company Information

Table 163. ICU Medical Description and Major Businesses

Table 164. ICU Medical Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 165. ICU Medical Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. ICU Medical Recent Developments

Table 167. Sarstedt Company Information

Table 168. Sarstedt Description and Major Businesses

Table 169. Sarstedt Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 170. Sarstedt Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 171. Sarstedt Recent Developments

Table 172. Sinocare Company Information

Table 173. Sinocare Description and Major Businesses

Table 174. Sinocare Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 175. Sinocare Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 176. Sinocare Recent Developments

Table 177. Yicheng Company Information

Table 178. Yicheng Description and Major Businesses

Table 179. Yicheng Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 180. Yicheng Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 181. Yicheng Recent Developments

Table 182. Yuwell Company Information

Table 183. Yuwell Description and Major Businesses

Table 184. Yuwell Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 185. Yuwell Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 186. Yuwell Recent Developments

Table 187. Greiner Bio One Company Information

Table 188. Greiner Bio One Description and Major Businesses

Table 189. Greiner Bio One Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 190. Greiner Bio One Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 191. Greiner Bio One Recent Developments

Table 192. Guangzhou iCare Medical Company Information

Table 193. Guangzhou iCare Medical Description and Major Businesses

Table 194. Guangzhou iCare Medical Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 195. Guangzhou iCare Medical Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 196. Guangzhou iCare Medical Recent Developments

Table 197. Shandong Lianfa Company Information

Table 198. Shandong Lianfa Description and Major Businesses

Table 199. Shandong Lianfa Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 200. Shandong Lianfa Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 201. Shandong Lianfa Recent Developments

Table 202. Tianjin Huahong Company Information

Table 203. Tianjin Huahong Description and Major Businesses

Table 204. Tianjin Huahong Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 205. Tianjin Huahong Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 206. Tianjin Huahong Recent Developments

Table 207. Owen Mumford Company Information

Table 208. Owen Mumford Description and Major Businesses

Table 209. Owen Mumford Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 210. Owen Mumford Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 211. Owen Mumford Recent Developments

Table 212. HemoCue Company Information

Table 213. HemoCue Description and Major Businesses

Table 214. HemoCue Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 215. HemoCue Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 216. HemoCue Recent Developments

Table 217. HTL-STREFA Company Information

Table 218. HTL-STREFA Description and Major Businesses

Table 219. HTL-STREFA Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 220. HTL-STREFA Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 221. HTL-STREFA Recent Developments

Table 222. UltiMed Company Information

Table 223. UltiMed Description and Major Businesses

Table 224. UltiMed Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 225. UltiMed Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 226. UltiMed Recent Developments

Table 227. SteriLance Medical Company Information

Table 228. SteriLance Medical Description and Major Businesses

Table 229. SteriLance Medical Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 230. SteriLance Medical Sterile Lancets Product Model Numbers, Pictures, Descriptions and Specifications

Table 231. SteriLance Medical Recent Developments

Table 232. Key Raw Materials Lists

Table 233. Raw Materials Key Suppliers Lists

Table 234. Sterile Lancets Distributors List

Table 235. Sterile Lancets Customers List

Table 236. Sterile Lancets Market Trends

Table 237. Sterile Lancets Market Drivers

Table 238. Sterile Lancets Market Challenges

Table 239. Sterile Lancets Market Restraints

Table 240. Research Programs/Design for This Report

Table 241. Key Data Information from Secondary Sources

Table 242. Key Data Information from Primary Sources

List of Figures

Figure 1. Sterile Lancets Product Picture

Figure 2. Global Sterile Lancets Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Sterile Lancets Market Share by Type: 2023 & 2030

Figure 4. Safety Lancets Product Picture

Figure 5. Ordinary Lancets Product Picture

Figure 6. Global Sterile Lancets Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Sterile Lancets Market Share by Application: 2023 & 2030

Figure 8. Children's Fingertip Blood Tests

Figure 9. Glucose Tests

Figure 10. Others

Figure 11. Sterile Lancets Report Years Considered

Figure 12. Global Sterile Lancets Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 14. Global Sterile Lancets Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 15. Global Sterile Lancets Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Sterile Lancets Revenue Market Share by Region (2019-2030)

Figure 17. Global Sterile Lancets Sales (2019-2030) & (K Units)

Figure 18. Global Sterile Lancets Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 19. Global Sterile Lancets Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Sterile Lancets Sales YoY (2019-2030) & (K Units)

Figure 21. US & Canada Sterile Lancets Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Sterile Lancets Sales YoY (2019-2030) & (K Units)

Figure 23. Europe Sterile Lancets Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Sterile Lancets Sales YoY (2019-2030) & (K Units)

Figure 25. China Sterile Lancets Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Sterile Lancets Sales YoY (2019-2030) & (K Units)

Figure 27. Asia (excluding China) Sterile Lancets Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Sterile Lancets Sales YoY (2019-2030) & (K Units)

Figure 29. Middle East, Africa and Latin America Sterile Lancets Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Global Sterile Lancets Sales Share by Manufacturers (2023)

Figure 31. The Sterile Lancets Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. Global Sterile Lancets Revenue Share by Manufacturers (2023)

Figure 33. The Top 5 and 10 Largest Manufacturers of Sterile Lancets in the World: Market Share by Sterile Lancets Revenue in 2023

Figure 34. Global Sterile Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 35. Global Sterile Lancets Sales Market Share by Type (2019-2030)

Figure 36. Global Sterile Lancets Revenue Market Share by Type (2019-2030)

Figure 37. Global Sterile Lancets Sales Market Share by Application (2019-2030)

Figure 38. Global Sterile Lancets Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Sterile Lancets Sales Market Share by Type (2019-2030)

Figure 40. US & Canada Sterile Lancets Revenue Market Share by Type (2019-2030)

Figure 41. US & Canada Sterile Lancets Sales Market Share by Application (2019-2030)

Figure 42. US & Canada Sterile Lancets Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Sterile Lancets Revenue Share by Country (2019-2030)

Figure 44. US & Canada Sterile Lancets Sales Share by Country (2019-2030)

Figure 45. US Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 46. Canada Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 47. Europe Sterile Lancets Sales Market Share by Type (2019-2030)

Figure 48. Europe Sterile Lancets Revenue Market Share by Type (2019-2030)

Figure 49. Europe Sterile Lancets Sales Market Share by Application (2019-2030)

Figure 50. Europe Sterile Lancets Revenue Market Share by Application (2019-2030)

Figure 51. Europe Sterile Lancets Revenue Share by Country (2019-2030)

Figure 52. Europe Sterile Lancets Sales Share by Country (2019-2030)

Figure 53. Germany Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 54. France Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 55. U.K. Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 56. Italy Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 57. Russia Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 58. China Sterile Lancets Sales Market Share by Type (2019-2030)

Figure 59. China Sterile Lancets Revenue Market Share by Type (2019-2030)

Figure 60. China Sterile Lancets Sales Market Share by Application (2019-2030)

Figure 61. China Sterile Lancets Revenue Market Share by Application (2019-2030)

Figure 62. Asia Sterile Lancets Sales Market Share by Type (2019-2030)

Figure 63. Asia Sterile Lancets Revenue Market Share by Type (2019-2030)

Figure 64. Asia Sterile Lancets Sales Market Share by Application (2019-2030)

Figure 65. Asia Sterile Lancets Revenue Market Share by Application (2019-2030)

Figure 66. Asia Sterile Lancets Revenue Share by Region (2019-2030)

Figure 67. Asia Sterile Lancets Sales Share by Region (2019-2030)

Figure 68. Japan Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 69. South Korea Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 70. China Taiwan Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 71. Southeast Asia Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 72. India Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 73. Australia Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Sterile Lancets Sales Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Sterile Lancets Revenue Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Sterile Lancets Sales Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Sterile Lancets Revenue Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Sterile Lancets Revenue Share by Country (2019-2030)

Figure 79. Middle East, Africa and Latin America Sterile Lancets Sales Share by Country (2019-2030)

Figure 80. Brazil Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 81. Mexico Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 82. Turkey Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 83. Israel Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 84. GCC Countries Sterile Lancets Revenue (2019-2030) & (US$ Million)

Figure 85. Sterile Lancets Value Chain

Figure 86. Sterile Lancets Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Sterile Lancets market? zhanKai

The top companies in the global Sterile Lancets market are Roche、Lifescan、BD.

What is the annual compound growth rate of the global Sterile Lancets market size from 2024 to 2030? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Sterile Lancets in 2024? shouQi

What was the global market size of Sterile Lancets in 2030? shouQi

Related Reports

Global Sterile Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Sterile Lancets market size was US$ 1744 million in 2025 and is forecast to reach a readjusted size of US$ 2383 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 114
USD 4250.00
(Single User License)
Global Sterile Lancets Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Sterile Lancets market is projected to grow from US$ 1744 million in 2025 to US$ 2383 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 188
USD 4900.00
(Single User License)
Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sterile Lancets was estimated to be worth US$ 1744 million in 2025 and is projected to reach US$ 2383 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 169
USD 3950.00
(Single User License)
Global Sterile Lancets Market Research Report 2026
The global Sterile Lancets market was valued at US$ 1744 million in 2025 and is anticipated to reach US$ 2383 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 145
USD 2900.00
(Single User License)
Global Sterile Lancets Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sterile Lancets market is projected to grow from US$ 1674 million in 2024 to US$ 2288 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 182
USD 4900.00
(Single User License)
Global Sterile Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sterile Lancets market size was US$ 1674 million in 2024 and is forecast to a readjusted size of US$ 2288 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 115
USD 4250.00
(Single User License)
Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sterile Lancets was estimated to be worth US$ 1674 million in 2024 and is forecast to a readjusted size of US$ 2288 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 159
USD 3950.00
(Single User License)
Global Sterile Lancets Market Research Report 2025
The global market for Sterile Lancets was valued at US$ 1674 million in the year 2024 and is projected to reach a revised size of US$ 2288 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published Date: 2025-02-25
Pages: 117
USD 2900.00
(Single User License)
Global and China Sterile Lancets Market Report & Forecast 2024-2030
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Published Date: 2024-10-23
Pages: 173
USD 4350.00
(Single User License)
Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Published Date: 2024-10-23
Pages: 169
USD 3950.00
(Single User License)

Global Sterile Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Sterile Lancets market size was US$ 1744 million in 2025 and is forecast to reach a readjusted size of US$ 2383 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 114
USD 4250.00 (Single User License)
Global Sterile Lancets Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Sterile Lancets market is projected to grow from US$ 1744 million in 2025 to US$ 2383 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 188
USD 4900.00 (Single User License)
Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Sterile Lancets was estimated to be worth US$ 1744 million in 2025 and is projected to reach US$ 2383 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-05
Pages: 169
USD 3950.00 (Single User License)
Global Sterile Lancets Market Research Report 2026
The global Sterile Lancets market was valued at US$ 1744 million in 2025 and is anticipated to reach US$ 2383 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-05
Pages: 145
USD 2900.00 (Single User License)
Global Sterile Lancets Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Sterile Lancets market is projected to grow from US$ 1674 million in 2024 to US$ 2288 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 182
USD 4900.00 (Single User License)
Global Sterile Lancets Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Sterile Lancets market size was US$ 1674 million in 2024 and is forecast to a readjusted size of US$ 2288 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 115
USD 4250.00 (Single User License)
Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Sterile Lancets was estimated to be worth US$ 1674 million in 2024 and is forecast to a readjusted size of US$ 2288 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 159
USD 3950.00 (Single User License)
Global Sterile Lancets Market Research Report 2025
The global market for Sterile Lancets was valued at US$ 1674 million in the year 2024 and is projected to reach a revised size of US$ 2288 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published: 2025-02-25
Pages: 117
USD 2900.00 (Single User License)
Global and China Sterile Lancets Market Report & Forecast 2024-2030
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Published: 2024-10-23
Pages: 173
USD 4350.00 (Single User License)
Sterile Lancets- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Published: 2024-10-23
Pages: 169
USD 3950.00 (Single User License)